ZSCAN22: A Key Regulator of Cell Growth and Differentiation (G342945)

Target Name: ZSCAN22

NCBI ID: G342945

ZSCAN22

ZSCAN22: A Key Regulator of Cell Growth and Differentiation

ZSCAN22, also known as Zinc finger and SCAN domain containing 22, is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues such as hair, nails, and bones. ZSCAN22 has also been shown to play a role in the regulation of inflammation and fibrosis.

One of the key features of ZSCAN22 is its unique genetic structure. It consists of a zinc finger domain, which is a common structural motif that is found in many proteins that regulate gene expression, as well as a SCAN domain, which is a conserved protein domain that is involved in protein-protein interactions. The zinc finger domain is responsible for the regulation of gene expression, while the SCAN domain is involved in the regulation of protein interactions and localization.

The function of ZSCAN22 is not well understood, but it is believed to play a key role in the regulation of cell growth and differentiation. It is expressed in various tissues and cells throughout the body, including hair, nail, and bone cells, and has been shown to be involved in the development and maintenance of these tissues. ZSCAN22 is also involved in the regulation of cell division, and has been shown to play a role in the regulation of cell cycle progression.

In addition to its role in cell growth and differentiation, ZSCAN22 is also thought to be involved in the regulation of inflammation and fibrosis. It has been shown to play a role in the regulation of immune responses and inflammation, and is also involved in the regulation of fibrosis, a condition in which tissues become abnormally organized and can cause a range of health problems.

Given its unique genetic structure and its involvement in the regulation of cell growth, differentiation, and inflammation, ZSCAN22 is a potential drug target or biomarker. Many studies have shown that blocking the activity of ZSCAN22 has potential therapeutic benefits, and further research is needed to fully understand its function and potential as a drug.

Protein Name: Zinc Finger And SCAN Domain Containing 22

Functions: May be involved in transcriptional regulation

The "ZSCAN22 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN22 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets